Compare Divis Laboratories with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ABBOTT INDIA - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ABBOTT INDIA DIVIS LABORATORIES/
ABBOTT INDIA
 
P/E (TTM) x 50.2 47.5 105.6% View Chart
P/BV x 13.4 15.4 87.4% View Chart
Dividend Yield % 0.5 0.4 101.7%  

Financials

 DIVIS LABORATORIES   ABBOTT INDIA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
ABBOTT INDIA
Mar-19
DIVIS LABORATORIES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,6398,834 18.6%   
Low Rs1,1155,458 20.4%   
Sales per share (Unadj.) Rs186.31,731.1 10.8%  
Earnings per share (Unadj.) Rs51.0211.9 24.0%  
Cash flow per share (Unadj.) Rs57.3219.9 26.1%  
Dividends per share (Unadj.) Rs16.0065.00 24.6%  
Dividend yield (eoy) %1.20.9 127.7%  
Book value per share (Unadj.) Rs261.8945.2 27.7%  
Shares outstanding (eoy) m265.4721.25 1,249.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.44.1 179.1%   
Avg P/E ratio x27.033.7 80.1%  
P/CF ratio (eoy) x24.032.5 73.9%  
Price / Book Value ratio x5.37.6 69.6%  
Dividend payout %31.430.7 102.4%   
Avg Mkt Cap Rs m365,592151,848 240.8%   
No. of employees `00011.83.5 339.9%   
Total wages/salary Rs m5,4234,356 124.5%   
Avg. sales/employee Rs Th4,175.110,555.5 39.6%   
Avg. wages/employee Rs Th457.71,249.9 36.6%   
Avg. net profit/employee Rs Th1,141.81,292.2 88.4%   
INCOME DATA
Net Sales Rs m49,46336,786 134.5%  
Other income Rs m1,5561,133 137.4%   
Total revenues Rs m51,01937,919 134.5%   
Gross profit Rs m18,7186,047 309.5%  
Depreciation Rs m1,689169 998.2%   
Interest Rs m3523 155.6%   
Profit before tax Rs m18,5516,989 265.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,0232,485 202.1%   
Profit after tax Rs m13,5274,503 300.4%  
Gross profit margin %37.816.4 230.2%  
Effective tax rate %27.135.6 76.1%   
Net profit margin %27.312.2 223.4%  
BALANCE SHEET DATA
Current assets Rs m46,50127,610 168.4%   
Current liabilities Rs m8,4688,569 98.8%   
Net working cap to sales %76.951.8 148.6%  
Current ratio x5.53.2 170.4%  
Inventory Days Days13160 217.2%  
Debtors Days Days8627 313.4%  
Net fixed assets Rs m25,7971,057 2,440.8%   
Share capital Rs m531213 249.8%   
"Free" reserves Rs m68,96219,873 347.0%   
Net worth Rs m69,49320,086 346.0%   
Long term debt Rs m00-   
Total assets Rs m80,38329,409 273.3%  
Interest coverage x531.0311.6 170.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.3 49.2%   
Return on assets %16.915.4 109.6%  
Return on equity %19.522.4 86.8%  
Return on capital %26.734.9 76.6%  
Exports to sales %00-   
Imports to sales %24.60-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m12,187NA-   
Fx inflow Rs m41,238369 11,176.7%   
Fx outflow Rs m12,4054,918 252.2%   
Net fx Rs m28,833-4,549 -633.8%   
CASH FLOW
From Operations Rs m9,5434,991 191.2%  
From Investments Rs m-6,854-2,570 266.7%  
From Financial Activity Rs m-2,459-1,428 172.2%  
Net Cashflow Rs m230993 23.1%  

Share Holding

Indian Promoters % 52.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 11.8 7.9 149.4%  
FIIs % 19.0 0.1 19,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 17.1 100.6%  
Shareholders   31,796 18,270 174.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT PHARMOVA   AJANTA PHARMA  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 447 Points Higher; Automobile & IT Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Mar 2, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - STRIDES PHARMA SCIENCE COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS